CUSTOMER SUPPORT

4DMEDICAL

Latest News

Learn about 4DMedical’s latest developments and future projects as well—all aimed at significantly improving early detection, diagnosis, and therapeutic strategies for a range of pulmonary conditions, including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.
12 November 2025

November 30 – December 4 | RSNA 2025 | Chicago, IL

The RSNA annual meeting is the world’s leading radiology forum; offering a robust research and education program, access to the latest medical imaging technologies and an array of opportunities for professional engagement and career advancement.
READ MORE
Early COPD Detection
10 October 2025

Catching COPD Early: Why Timing Could Save Your Lungs

Chronic Obstructive Pulmonary Disease, or COPD, is one of the most common lung conditions in the world—yet it remains deeply underdiagnosed. In the United States alone, over 12.5 million people are known to have COPD, but millions more may be living with it. One of the main reasons for this
READ MORE
4DMedical CT:VQ - Then: Structural Only and Now: See the Physiology
12 September 2025

CT:VQ™ Redefines Lung Imaging: FDA Clearance Makes Non-Contrast V/Q Scans a Reality

In a landmark move for pulmonary diagnostics, 4DMedical’s CT:VQ™ earned FDA 510(k) clearance in September 2025, marking it as the first and only non-contrast ventilation–perfusion (V/Q) imaging solution. The technology is available via routine chest CT scans. With CMS confirming reimbursement under Category III CPT codes (on top of the
READ MORE
CT:VQ™ Non-Contrast Lung Ventilation Perfusion
04 September 2025

4DMedical’s CT:VQ™ Receives FDA 510(k) Clearance; First-and-Only Non-Contrast VQ Imaging

4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world’s first and only non-contrast, ventilation–perfusion (VQ) imaging solution. In parallel, the U.S. Centers for Medicare & Medicaid Services (CMS) has confirmed reimbursement for CT:VQ under Category III CPT codes;
READ MORE
31 August 2025

February 21-25 | Society of Thoracic Radiology (STR) | El Conquistador Resort, Puerto Rico

The Society of Thoracic Radiology (STR) Conference will be an engaging and dynamic event for radiologists specializing in thoracic imaging. Set against the scenic backdrop of the Pacific Ocean, the conference will feature cutting-edge presentations on the latest advancements in thoracic imaging technologies, as well as in-depth discussions on clinical
READ MORE
25 August 2025

March 27-31 | TSANZSRS | Perth, AUS

This joint meeting of the Thoracic Society of Australia and New Zealand (TSANZ) and the Australian and New Zealand Society of Respiratory Science (ANZSRS) will explore key issues in lung health and respiratory science.
READ MORE
20 August 2025

MAY 15-20 | American Thoracic Society (ATS) | Orlando, FL

The ATS International Conference brings together nearly 14,000 pulmonary and critical care professionals from around the world to share the latest research, foster collaborations, and improve patient care. With diverse participation across disciplines, it also serves as a key forum for healthcare teams to discuss advances in understanding and treating
READ MORE
Veterans holding their lungs - color-mapped with XV LVAS®
15 July 2025

New Study Underscores XV Technology’s Power to Detect Hidden Lung Disease

A major new multi-center study published in Respiratory Research (July 2025) demonstrates that 4DMedical’s X-ray Velocimetry Lung Ventilation Analysis Software (XV LVAS®) can reveal early and subtle forms of small airways disease that are often missed by standard tests like spirometry and CT scans. Researchers from Vanderbilt University, Johns Hopkins,
READ MORE
XV LVAS - XV Scanner Bronchiectasis
11 July 2025

Innovative XV Technology Shows Promise for Detailed Lung Function Assessment in Bronchiectasis Patients

A new study led by UNSW Sydney researchers demonstrates the feasibility and promise of the innovative XV Scanner™ with XV LVAS®, non-invasive imaging tools developed by 4DMedical, for assessing regional lung function in adults with bronchiectasis caused by Primary Ciliary Dyskinesia (PCD) and other conditions.
READ MORE

What's new at 4DMedical

Get the latest news about respiratory imaging and ventilation analysis
CUSTOMER SUPPORT